Moonshots with Peter Diamandis cover image

Cathie Wood on the Bitcoin Halving, Apple/Open AI & NVDIAs Dominance w/ Cathie Wood | EP #108

Moonshots with Peter Diamandis

00:00

Focus on Safety First, Efficacy Follows in CRISPR Therapeutics

CRISPR Therapeutics prioritized safety over efficacy in their therapies for beta thalassemia and sickle cell disease, as emphasized by Jennifer Doudna. The successful approval of these therapies in the US, UK, and Europe demonstrates their effective approach. Despite the significant advancements in curing diseases, the market remains focused on short-term concerns and fails to recognize the vast potential of gene-editing technologies. The pharmaceutical industry faces challenges due to the emphasis on revenues over innovative potential.

Play episode from 01:06:54
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app